BCTX Briacell Therapeutics Corp.

Fundamentals / CIK 0001610820 / USD
Other share classes on CIK 0001610820: BCTXL BCTXZ

Briacell Therapeutics Corp. reported $23.58M in total assets and a net loss of $34.90M through July 31, 2026 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open BCTX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2021 to 2026), reported in USD.

$0$0$0-$32.64MFY 2021 Net Income: -$13.82M2021FY 2022 Net Income: -$26.84M2022FY 2023 Net Income: -$20.30M2023FY 2024 Net Income: -$4.79M2024FY 2025 Net Income: -$26.31M2025FY 2026 Net Income: -$34.90M2026

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Jul 31 Jul 31 Jul 31 Jul 31 Jul 31 Jul 31
Research & Development $29.24M $21.27M $27.18M $15.34M $8.02M $2.02M
Total Operating Expenses $36.05M $27.20M $33.33M $23.27M -- --
Operating Income -$36.05M -$27.20M -$33.33M -$23.27M -$15.29M -$6.98M
EBITDA -$35.93M -$27.10M -$33.25M -- -$15.27M -$6.96M
Interest Income $634K $120K $288K $891K $137K $3.1K
Interest Expense $30K $37K -- -- $979 $79K
Income Before Tax $35.33M $26.56M $4.93M $20.30M -$26.84M -$13.82M
Net Income -$34.90M -$26.31M -$4.79M -$20.30M -$26.84M -$13.82M
Basic EPS -$6.97 -$62.19 -$436.80 -$29,104.48 -$38,731.34 -$68,507.46
Diluted EPS -$6.97 -$62.19 -$436.80 -$29,104.48 -$38,731.34 --
Basic Shares Outstanding 5.0M 423.1K 11.0K 698 692 202
Diluted Shares Outstanding 5.0M 423.1K 11.0K 698 692 --

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-07-31 2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Research & Development $10.53M $5.97M $6.05M $6.68M $7.11M $4.81M $5.68M $3.67M
Total Operating Expenses $12.58M $7.62M $7.53M $8.32M $8.55M $6.33M $7.17M $5.15M
Operating Income -$12.58M -$7.62M -$7.53M -$8.32M -$8.55M -$6.33M -$7.17M -$5.15M
EBITDA -$12.55M -$7.59M -$7.50M -$8.30M -$8.53M -$6.30M -$7.14M -$5.13M
Interest Income $171K $219K $106K $48K $33K $27K $47K $13K
Interest Expense -- $30K -- -- -- $37K -- --
Net Income -$12.32M -$7.16M -$7.22M -$8.20M -$8.09M -$6.13M -$6.29M -$5.80M
Basic EPS -- -$0.99 -$2.58 -$43.50 -- -$16.42 -$23.31 -$326.70
Diluted EPS -- -$0.99 -$2.58 -$43.50 -- -$16.42 -$23.31 -$326.70
Basic Shares Outstanding -- 7.3M 2.8M 188.4K -- 373.1K 270.0K 17.8K
Diluted Shares Outstanding -- 7.3M 2.8M 188.4K -- 373.1K 270.0K 17.8K

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Jul 31 Jul 31 Jul 31 Jul 31 Jul 31 Jul 31
Cash & Cash Equivalents $9.85M $10.49M $862K $21.25M $41.04M $57.27M
Short-Term Investments $10.69M $7.37M -- -- -- --
Cash & Short-Term Investments $20.54M $17.87M $862K $21.25M $41.04M $57.27M
Accounts Receivable, Net -- -- -- $19K $24K $13K
Total Current Assets $22.04M $19.93M $3.65M $26.95M $42.35M $57.80M
Property, Plant & Equipment, Net $320K $297K $388K $2.5K $2.5K --
Intangible Assets $169K $185K $200K $215K $230K $246K
Total Non-Current Assets $1.53M $1.72M $2.22M $215K $230K $246K
Total Assets $23.58M $21.65M $5.87M $27.16M $42.58M $58.04M
Accounts Payable $6.99M $3.28M $7.17M $1.12M $463K $214K
Total Current Liabilities $7.98M $3.98M $7.46M $1.80M $941K $557K
Total Non-Current Liabilities $39K $338K $1.10M $29.14M $31.31M $29.82M
Total Liabilities $8.02M $4.32M $8.56M $30.94M $32.25M $30.37M
Common Stock $120.9M $101.7M $72.17M $69.59M $65.59M $54.77M
Retained Earnings -$146.7M -$111.8M -$85.44M -$80.65M -$60.35M -$29.14M
Accumulated Other Comp. Income -$139K -$139K -$139K -$139K -$139K -$139K
Total Stockholders' Equity -- -- -- -$3.78M $10.33M $27.67M
Total Equity $15.56M $17.33M -$2.68M -$3.78M $10.33M $27.67M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-07-31 2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Cash & Cash Equivalents $9.85M $6.88M $29.90M $2.71M $10.49M $12.46M $5.01M $5.79M
Short-Term Investments $10.69M $15.92M -- $7.46M $7.37M -- -- --
Cash & Short-Term Investments $20.54M $22.80M $29.90M $10.18M $17.87M $12.46M $5.01M $5.79M
Total Current Assets $22.04M $25.39M $32.18M $11.35M $19.93M $14.79M $7.16M $8.22M
Property, Plant & Equipment, Net $320K $349K $251K $274K $297K $320K $342K $365K
Intangible Assets $169K -- -- $181K $185K $188K $192K $196K
Total Non-Current Assets $1.53M $1.68M $1.42M $1.73M $1.72M $2.22M $2.20M $2.20M
Total Assets $23.58M $27.07M $33.59M $13.08M $21.65M $17.00M $9.36M $10.41M
Accounts Payable $6.99M $2.17M $1.88M $2.13M $3.28M $3.28M $5.00M $4.23M
Total Current Liabilities $7.98M $3.59M $3.19M $3.32M $3.98M $4.33M $5.23M $4.99M
Total Non-Current Liabilities $39K $72K $195K $407K $338K $730K $906K $1.71M
Total Liabilities $8.02M $3.66M $3.38M $3.72M $4.32M $5.06M $6.14M $6.70M
Common Stock $120.9M $117.1M $117.1M $101.7M $101.7M $94.02M $85.45M $82.04M
Retained Earnings -$146.7M -$134.3M -$127.2M -$120.0M -$111.8M -$103.7M -$97.54M -$91.25M
Accumulated Other Comp. Income -$139K -$139K -$139K -$139K -$139K -$139K -$139K -$139K
Total Equity $15.56M $23.41M $30.21M $9.35M $17.33M $11.94M $3.23M $3.71M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Jul 31 Jul 31 Jul 31 Jul 31 Jul 31 Jul 31
Net Income -$35.33M -$26.56M -$4.93M -$20.30M -$26.84M -$13.82M
Depreciation & Amortization $119K $107K $84K -- $15K $15K
Stock-Based Compensation $1.13M $657K $1.80M $2.19M $3.07M $1.97M
Change in Receivables -$3.2K $734K -$733K $5.2K -$12K $9.9K
Change in Payables $3.71M -$3.89M $6.05M $660K $249K -$1.41M
Operating Cash Flow -$28.65M -$28.17M -$24.13M -$23.74M -$12.48M -$7.75M
Capital Expenditure -$127K -- -$457K -- -- --
Free Cash Flow -$28.78M -- -$24.58M -- -- --
Purchases of Investments -$377K -$330K -$225K -- -- --
Investing Cash Flow -$3.81M -$7.65M -$682K -- -- --
Common Stock Issued $31.81M $44.63M $4.42M $4.00M -- --
Share Repurchases -- -- -- -$47K -$10.17M --
Financing Cash Flow $31.81M $45.45M $4.42M $3.95M -$3.74M $65.00M
Net Change in Cash -$641K $9.63M -$20.39M -$19.79M -$16.23M $57.25M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-07-31 2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Net Income -$12.51M -$7.24M -$7.30M -$8.28M -$8.16M -$6.22M -$6.34M -$5.83M
Depreciation & Amortization $33K $33K $27K $27K $27K $27K $27K $27K
Stock-Based Compensation $118K $432K $286K $295K -$120K $225K $285K $267K
Change in Receivables -- -- -- -- $514 $9.9K -$14K $737K
Change in Payables $4.82M $295K -$249K -$1.15M $4.5K -$1.72M $769K -$2.94M
Operating Cash Flow -$5.96M -$7.02M -$7.97M -$7.70M -$8.13M -$7.16M -$5.92M -$6.96M
Purchases of Investments -$117K -$95K -$90K -$75K -$75K -$105K -$75K -$75K
Investing Cash Flow $4.99M -$16.00M $7.28M -$75K -$7.39M -$105K -$75K -$75K
Common Stock Issued -- -- -- -- $13.56M $14.71M $4.69M $11.67M
Financing Cash Flow -- -- -- -- $13.56M $14.71M $5.22M $11.96M
Net Change in Cash $2.97M -$23.02M $27.19M -$7.78M -$1.97M $7.45M -$779K $4.93M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Jul 31 Jul 31 Jul 31 Jul 31 Jul 31 Jul 31
Return on Equity (ROE) -- -- -- -- -259.8% -49.9%
Return on Assets (ROA) -148.0% -121.5% -81.6% -74.7% -63.0% -23.8%
Current Ratio 2.76x 5.01x 0.49x 14.96x 45.00x 103.81x
Quick Ratio 2.57x 4.49x 0.12x 11.81x 43.64x 102.88x

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-07-31 2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Return on Assets (ROA) -148.0% -113.3% -88.2% -219.6% -121.5% -114.3% -123.8% -159.3%
Current Ratio 2.76x 7.07x 10.10x 3.42x 5.01x 3.41x 1.37x 1.65x
Quick Ratio 2.57x 6.35x 9.39x 3.07x 4.49x 2.88x 0.96x 1.16x
Net Income Growth (YoY) -- -- -- -- -- -457.1% -- -196.7%
EPS Growth (YoY) -- -- -- -- -- -100.7% -- -103.8%
Source: SEC EDGAR CompanyFacts (CIK 0001610820) · from July 31, 2021 Data through July 31, 2026 · synced Nov 21, 2026, 05:01 UTC · Open in terminal